The lower price will apply to the four largest federal government agencies that provide health services, as well as other agencies. Gilead Pharmaceutical Company will also want the same amount from the governments of other developed countries. Which they are, but the company did not specifically state. The CNN portal writes about it.
Private US insurance companies will have to pay a higher price. For one dose, it will be $ 520 (over 12 thousand crowns), a five-day treatment that includes six applications of the drug, so it will cost $ 3,120 (about 74 thousand crowns). The company informed about it in an open letter on Monday.
“Under normal circumstances, we would value the drug according to its true value. The first results of studies showed that Remdesivir shortens the hospital stay by an average of four days. In the US, for example, earlier discharge from hospital saves $ 12,000. said the company.
However, because Remdesivir is the only approved drug for patients with Covid-19 in the United States, the company opted for a significantly lower price. Remdesivir will be paid even less than recommended by the US Institute for Clinical and Economic Review.
The European Medicines Agency has already recommended that Remdesivir be approved quickly for those infected with Covid-19. In the Czech Republic, the drug is currently listed as experimental. The most famous patient, in whom he contributed to the improvement of his health condition, is a taxi driver who was treated at the General University Hospital in Prague. Check out a report on his case: